We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

MACULAR DEGENERATION TREATMENT MARKET ANALYSIS

Macular Degeneration Treatment Market, By Type (Dry Age-related Macular Degeneration and Wet Age-related Macular Degeneration), By Stage Of Disease (Early-stage AMD, Intermediate AMD, and Late-stage AMD), By Route Of Administration (Intravenous Route and Intravitreal Route), By Sales Channel (Ambulatory Surgical Centres, Hospitals, and Other Sales Channels), and By Geography (North America Europe, Asia-Pacific, South America, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

  • Published In : Aug 2022
  • Code : CMI5149
  • Pages :174
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Companies covered:

Bayer AG, REGENXBIO Inc., Aerie Pharmaceutical Inc., Panoptica, Pfizer Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceutical Inc., Novartis AG, and Bausch Health Companies Inc., among others

Competitive Landscape:

  1. Hoffmann-La Roche Ltd
  2. Novartis AG
  3. Pfizer Inc.
  4. Panoptica
  5. Bausch Health Companies Inc.
  6. Regeneron Pharmaceutical Inc.
  7. Aerie Pharmaceutical Inc.
  8. REGENXBIO Inc.
  9. Bayer AG

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.